Maxx Orthopedics announced FDA 510(k) clearance of its new asymmetrical Porous Tibial Baseplate for the Freedom Total Knee. With the introduction of the 3D-printed baseplate, the Freedom Total Knee System now offers a cementless tibiofemoral solution.
Key features of the Porous Tibial Baseplate include:
Porous surface technology, designed to promote osseointegration and long-term biological fixation
Cementless fixation option, providing an alternative for surgeons seeking to minimize cement-related complications while maximizing bone preservation.
Asymmetric design, to optimize coverage of the resected proximal tibial plateau, ensuring better load distribution and anatomical fit.
“With the introduction of our Porous Tibial Baseplate, we are expanding the capabilities of the Freedom Total Knee System to address the needs of surgeons and their patients,” said Farzin Khaghani, Chief Commercial Officer. “This latest innovation reflects our commitment to advancing cementless knee solutions.”
The Freedom Porous Tibial Baseplate is approved for use in the United States and will be available for clinical use mid-2025.
Maxx Orthopedics announced FDA 510(k) clearance of its new asymmetrical Porous Tibial Baseplate for the Freedom Total Knee. With the introduction of the 3D-printed baseplate, the Freedom Total Knee System now offers a cementless tibiofemoral solution.
Key features of the Porous Tibial Baseplate include:
Porous surface technology, designed...
Maxx Orthopedics announced FDA 510(k) clearance of its new asymmetrical Porous Tibial Baseplate for the Freedom Total Knee. With the introduction of the 3D-printed baseplate, the Freedom Total Knee System now offers a cementless tibiofemoral solution.
Key features of the Porous Tibial Baseplate include:
Porous surface technology, designed to promote osseointegration and long-term biological fixation
Cementless fixation option, providing an alternative for surgeons seeking to minimize cement-related complications while maximizing bone preservation.
Asymmetric design, to optimize coverage of the resected proximal tibial plateau, ensuring better load distribution and anatomical fit.
“With the introduction of our Porous Tibial Baseplate, we are expanding the capabilities of the Freedom Total Knee System to address the needs of surgeons and their patients,” said Farzin Khaghani, Chief Commercial Officer. “This latest innovation reflects our commitment to advancing cementless knee solutions.”
The Freedom Porous Tibial Baseplate is approved for use in the United States and will be available for clinical use mid-2025.
Copy to clipboard 
